Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|June 10, 2010
Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathwaysKaren Mendelson, Steven Swendeman, Paul Saftig, et al.
Surgery|December 6, 2021
Plasma components to protect the endothelial barrier after shock: A role for sphingosine 1-phosphateLawrence N Diebel, David M Liberati, Timothy Hla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular InjuryNathalie Burg, Steven Swendeman, Stefan Worgall, et al.
Molecular and Cellular Biology|March 11, 2009
ADAM9 is involved in pathological retinal neovascularizationVictor Guaiquil, Steven Swendeman, Tsunehiko Yoshida, et al.
The Biochemical Journal|March 8, 2017
Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assaysThorsten Maretzky, Steven Swendeman, Elin Mogollon, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 2, 2010
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in miceVictor H Guaiquil, Steven Swendeman, Wenhui Zhou, et al.
Circulation Research|September 27, 2008
VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signalingSteven Swendeman, Karen Mendelson, Gisela Weskamp, et al.
EMBO Molecular Medicine|March 13, 2023
Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularizationColin Niaudet, Bongnam Jung, Andrew Kuo, et al.
Journal of Lipid Research|August 30, 2019
Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient miceHideru Obinata, Andrew Kuo, Yukata Wada, et al.
Investigative Ophthalmology & Visual Science|January 10, 2013
Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in miceNina Jasmin Hewing, Gisela Weskamp, Joost Vermaat, et al.
Pageof 2